Board to approve Q2 and half-year results on 5 November 2026

Revenue growth above 20%Exceptional itemResults View source PDF Explain this filing

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹1460.00

prior close

₹1462.30

announcement price

After-mkt

timing

Nifty Smallcap 250market-2.0%+1.8% vs market

Medical Equipment & Supplies peers, median of 12sector-1.6%+1.4% vs sector

On the reaction day the stock moved 1.8 pts more than Nifty Smallcap 250 and 1.4 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-0.6

15m

-0.5

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-2.0+1.8-1.6+1.4

Next day

+1.2-0.6+1.8-1.7+2.9

+2.7-0.2+3.0-1.6+4.3

+9.6+1.7+7.9+1.6+7.9

+10.6+2.5+8.1+4.1+6.5

+11.0pendingpending+1.3+9.7

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Poly Medicure will hold a Board meeting on 5 November 2026 to approve unaudited standalone and consolidated results for the quarter and half-year ended 30 September 2026. The trading window remains closed until 7 November. No financial figures or auditor change are disclosed.

Likely market impact

No performance numbers are provided. The stock may react when the results are announced on 5 November.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹580.5 Cr	₹443.9 Cr	+30.8%
Operating profit	₹95.37 Cr	₹86.78 Cr	+9.9%
Profit after tax	₹95.13 Cr	₹91.80 Cr	+3.6%
EBITDA margin	25.3%	25.8%	−0.5 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.